Clinical Trials
9 trialsNCT07417189 2026-03-11
A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )
Abbisko Therapeutics Co, Ltd
Phase 1/2 Recruiting
NCT05972720 2025-05-15
FIRCE-1
CARGO Therapeutics
Phase 2 Terminated
NCT04111107 2024-07-03
Precision Medicine for Patients With Identified Actionable Mutations
Wake Forest University Health Sciences
Phase 2 Terminated
NCT05768503 2023-03-14
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Sun Yat-sen University
Phase 3 Recruiting
NCT05409417 2022-06-08
Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2/3 Unknown
NCT03113825 2021-06-11
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Avelas Biosciences, Inc.
Phase 2 Completed
NCT00040391 2016-12-01
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Celgene Corporation
Phase 2 Terminated
NCT00034957 2012-02-16
Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)
Pfizer
Phase 2 Completed
NCT00036140 2005-06-24
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
Pfizer
Phase 1 Completed